COMMUNIQUÉS West-GlobeNewswire
-
EMERGENT BIOSOLUTIONS ET VALNEVA INITIENT UNE ETUDE CLINIQUE DE PHASE I POUR EVALUER LEUR CANDIDAT VACCIN CONTRE LE VIRUS ZIKA
26/02/2018 - 22:22 -
Almost Family Reports Fourth Quarter and Full Year 2017 Results
26/02/2018 - 22:22 -
Alder BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
26/02/2018 - 22:15 -
Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus
26/02/2018 - 22:15 -
HTG Announces New Australian Patent for Its Technology
26/02/2018 - 22:05 -
OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018
26/02/2018 - 22:05 -
Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017
26/02/2018 - 22:05 -
Antares Pharma to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference
26/02/2018 - 22:01 -
Collegium to Host Conference Call to Discuss Fourth Quarter 2017 Financial Results and Provide Corporate Update
26/02/2018 - 22:01 -
Tyme Technologies Announces Offering of Common Stock
26/02/2018 - 22:01 -
2018 First Half Year Financial Results Webcast for Mesoblast
26/02/2018 - 22:00 -
Healthwise Announces Elizabeth Beem as Chief Financial Officer
26/02/2018 - 21:01 -
TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer
26/02/2018 - 21:00 -
SuperSonic Imagine to present Aixplorer® Ultimate at the European Congress of Radiology (ECR 2018)
26/02/2018 - 20:00 -
OncBioMune Provides Updates on two Phase 2 Clinical Trials of ProscaVax for Prostate Cancer
26/02/2018 - 18:47 -
Solon Eiendom ASA : Invitation to presentation of fourth quarter 2017 results
26/02/2018 - 18:06 -
Ossur Hf : Transactions in relation to share buyback program
26/02/2018 - 17:00 -
Voyager Therapeutics to Present at Cowen Health Care Conference
26/02/2018 - 16:57 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - last conversion of Bracknor financing programme
26/02/2018 - 16:30
Pages